Stryker Corporation logo
Stryker Corporation (SYK)
Compare

Stryker Corporation (SYK) Free Cash Flow Yield: 3.81%

popular:market cap|pe ratio|revenue|price history|total return

Is Stryker Corporation’s free cash flow yield high or low?

Stryker Corporation's free cash flow yield of 3.81% is 50% above its 5-year average of 2.53%, near the high end of its 5-year range (1.75%–4.19%).

As of Wednesday, June 17, 2026. 29.36% above its 12-month average of 2.95%.

Free Cash Flow CAGR|Earnings Yield|Dividend Yield|P/FCF Ratio|All Metrics

SYK Free Cash Flow Yield Chart

SYK Free Cash Flow Yield
3.81%+55.51% 1Y
Zoom

SYK Average Free Cash Flow Yield Chart

SYK Current vs Average Free Cash Flow Yield Chart

SYK Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

3.81%

FREE CASH FLOW YIELD AVG TTM

2.95%

FREE CASH FLOW YIELD AVG 3Y

2.43%

FREE CASH FLOW YIELD AVG 5Y

2.51%

FREE CASH FLOW YIELD AVG 10Y

2.46%

FREE CASH FLOW YIELD AVG 15Y

3.28%

FREE CASH FLOW YIELD AVG 20Y

3.64%

CURRENT VS TTM AVG

+29.36%

CURRENT VS 3Y AVG

+56.91%

CURRENT VS 5Y AVG

+51.50%

CURRENT VS 10Y AVG

+54.98%

CURRENT VS 15Y AVG

+16.14%

CURRENT VS 20Y AVG

+4.57%

SYK Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
Stryker Corporation (SYK)$119.06B3.81%2.95%2.43%2.51%
Bristol-Myers Squibb Company (BMY)vs ›$114.38B10.36%13.28%12.27%10.96%
Vertex Pharmaceuticals Incorporated (VRTX)vs ›$113.82B3.21%3.06%3.42%3.84%
CVS Health Corporation (CVS)vs ›$127.54B5.74%6.51%9.19%10.65%
Danaher Corporation (DHR)vs ›$128.72B4.11%3.50%3.47%3.67%
Medtronic plc (MDT)vs ›$104.05B5.24%4.52%4.49%4.32%
Intuitive Surgical, Inc. (ISRG)vs ›$148.26B1.89%1.29%0.87%1.09%
Pfizer Inc. (PFE)vs ›$148.76B6.37%7.33%5.92%7.34%
HCA Healthcare, Inc. (HCA)vs ›$88.05B8.81%7.02%6.37%6.14%
Elevance Health Inc. (ELV)vs ›$86.74B7.28%5.93%5.03%6.06%

Yield Comparison

FCF Yield

3.81%

Earnings Yield

2.78%

Dividend Yield

1.11%

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

Stryker Corporation Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Stryker Corporation Free Cash Flow Yield FAQ

What is the free cash flow yield for Stryker Corporation (SYK)?
The free cash flow yield for SYK stock is 3.81%.
Is Stryker Corporation's free cash flow yield high or low?
Stryker Corporation's free cash flow yield of 3.81% is 50% above its 5-year average of 2.53%, near the high end of its 5-year range (1.75%–4.19%).
What is the TTM average free cash flow yield for Stryker Corporation (SYK)?
The TTM average free cash flow yield for SYK stock is 2.95%.
What is the 3Y average free cash flow yield for Stryker Corporation (SYK)?
The 3Y average free cash flow yield for SYK stock is 2.43%.
What is the 5Y average free cash flow yield for Stryker Corporation (SYK)?
The 5Y average free cash flow yield for SYK stock is 2.51%.
What is the 10Y average free cash flow yield for Stryker Corporation (SYK)?
The 10Y average free cash flow yield for SYK stock is 2.46%.
What is the 15Y average free cash flow yield for Stryker Corporation (SYK)?
The 15Y average free cash flow yield for SYK stock is 3.28%.
What is the 20Y average free cash flow yield for Stryker Corporation (SYK)?
The 20Y average free cash flow yield for SYK stock is 3.64%.

Stryker Corporation Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-163.81%
2026-06-153.84%
2026-06-123.79%
2026-06-113.87%
2026-06-103.83%
2026-06-093.77%
2026-06-083.92%
2026-06-053.87%
2026-06-043.93%
2026-06-034.01%
2026-06-024.03%
2026-06-013.95%
2026-05-293.88%
2026-05-283.84%
2026-05-273.87%
2026-05-263.78%
2026-05-223.74%
2026-05-213.77%
2026-05-203.68%
2026-05-193.72%
2026-05-183.78%
2026-05-153.86%
2026-05-143.87%
2026-05-133.92%
2026-05-124.02%
2026-05-114.19%
2026-05-083.88%
2026-05-073.77%
2026-05-063.79%
2026-05-053.75%
2026-05-043.81%
2026-05-013.76%
2026-04-303.52%
2026-04-293.52%
2026-04-283.45%
2026-04-273.37%
2026-04-243.38%
2026-04-233.36%
2026-04-223.36%
2026-04-213.39%
2026-04-203.28%
2026-04-173.23%
2026-04-163.27%
2026-04-153.25%
2026-04-143.20%
2026-04-133.19%
2026-04-103.27%
2026-04-093.27%
2026-04-083.26%
2026-04-073.34%
2026-04-063.33%
2026-04-023.34%
2026-04-013.36%
2026-03-313.37%
2026-03-303.40%
2026-03-273.38%
2026-03-263.33%
2026-03-253.38%
2026-03-243.37%
2026-03-233.33%
2026-03-203.30%
2026-03-193.26%
2026-03-183.20%
2026-03-173.17%
2026-03-163.17%
2026-03-133.29%
2026-03-123.29%
2026-03-113.21%
2026-03-103.09%
2026-03-093.03%
2026-03-063.04%
2026-03-052.99%
2026-03-042.90%
2026-03-032.88%
2026-03-022.86%
2026-02-272.86%
2026-02-262.87%
2026-02-252.89%
2026-02-242.91%
2026-02-232.88%
2026-02-202.91%
2026-02-192.97%
2026-02-182.94%
2026-02-173.00%
2026-02-133.03%
2026-02-123.03%
2026-02-113.05%
2026-02-102.92%
2026-02-092.96%
2026-02-062.94%
2026-02-052.91%
2026-02-042.92%
2026-02-032.92%
2026-02-022.86%
2026-01-302.85%
2026-01-292.97%
2026-01-282.94%
2026-01-272.97%
2026-01-262.95%
2026-01-232.97%
2026-01-222.94%
2026-01-212.90%
2026-01-202.93%
2026-01-162.90%
2026-01-152.91%
2026-01-142.93%
2026-01-132.96%
2026-01-122.91%
2026-01-092.87%
2026-01-082.87%
2026-01-072.86%
2026-01-062.87%
2026-01-053.02%
2026-01-023.02%
2025-12-313.00%
2025-12-302.97%
2025-12-292.99%
2025-12-262.97%
2025-12-242.97%
2025-12-232.97%
2025-12-222.95%
2025-12-192.97%
2025-12-182.98%
2025-12-172.99%
2025-12-162.99%
2025-12-152.96%
2025-12-122.97%
2025-12-112.98%
2025-12-102.98%
2025-12-093.02%
2025-12-082.98%
2025-12-052.89%
2025-12-042.89%
2025-12-032.88%
2025-12-022.87%
2025-12-012.83%
2025-11-282.84%
2025-11-262.83%
2025-11-252.81%
2025-11-242.84%
2025-11-212.86%
2025-11-202.92%
2025-11-192.89%
2025-11-182.93%
2025-11-172.92%
2025-11-142.91%
2025-11-132.82%
2025-11-122.87%
2025-11-112.90%
2025-11-102.97%
2025-11-072.96%
2025-11-062.98%
2025-11-052.94%
2025-11-042.90%
2025-11-032.94%
2025-10-312.96%
2025-10-302.82%
2025-10-292.82%
2025-10-282.77%
2025-10-272.71%
2025-10-242.73%
2025-10-232.72%
2025-10-222.68%
2025-10-212.74%
2025-10-202.73%
2025-10-172.78%
2025-10-162.82%
2025-10-152.82%
2025-10-142.81%
2025-10-132.85%
2025-10-102.86%
2025-10-092.81%
2025-10-082.77%
2025-10-072.82%
2025-10-062.84%
2025-10-032.81%
2025-10-022.84%
2025-10-012.86%
2025-09-302.82%
2025-09-292.82%
2025-09-262.82%
2025-09-252.83%
2025-09-242.81%
2025-09-232.79%
2025-09-222.75%
2025-09-192.76%
2025-09-182.76%
2025-09-172.76%
2025-09-162.77%
2025-09-152.76%
2025-09-122.72%
2025-09-112.68%
2025-09-102.72%
2025-09-092.65%
2025-09-082.65%
2025-09-052.65%
2025-09-042.64%
2025-09-032.68%
2025-09-022.67%
2025-08-292.66%
2025-08-282.67%
2025-08-272.65%
2025-08-262.64%
2025-08-252.66%
2025-08-222.64%
2025-08-212.71%
2025-08-202.66%
2025-08-192.67%
2025-08-182.73%
2025-08-152.73%
2025-08-142.75%
2025-08-132.75%
2025-08-122.77%
2025-08-112.76%
2025-08-082.76%
2025-08-072.77%
2025-08-062.78%
2025-08-052.73%
2025-08-042.73%
2025-08-012.76%
2025-07-312.36%
2025-07-302.31%
2025-07-292.31%
2025-07-282.31%
2025-07-252.29%
2025-07-242.33%
2025-07-232.31%
2025-07-222.34%
2025-07-212.39%
2025-07-182.38%
2025-07-172.38%
2025-07-162.37%
2025-07-152.37%
2025-07-142.36%
2025-07-112.38%
2025-07-102.35%
2025-07-092.36%
2025-07-082.38%
2025-07-072.36%
2025-07-032.34%
2025-07-022.36%
2025-07-012.33%
2025-06-302.34%
2025-06-272.35%
2025-06-262.37%
2025-06-252.36%
2025-06-242.40%
2025-06-232.44%
2025-06-202.46%
2025-06-182.48%
2025-06-172.48%
2025-06-162.45%
2025-06-132.45%
2025-06-122.43%
2025-06-112.43%
2025-06-102.40%
2025-06-092.42%
2025-06-062.41%
2025-06-052.42%
2025-06-042.42%

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

Related Metrics

Free Cash Flow CAGREarnings YieldDividend YieldP/FCF RatioAll Metrics

About Stryker Corporation

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Portage, MI
53,000 employees
www.stryker.com
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Kevin A. Lobo
View full financials